The vfa

The number of people employed at vfa companies increased slightly over the past year, as has the number of those employed in R&D. The R&D share (the number of R&D employees divided by the total number of employees) is 23.4 percent; almost one-quarter of all vfa employees work in this field. Investment in research and development by
the research-based pharmaceutical companies has risen again over the past year. With more than EUR 5 billion invested, the members are active in one of the most research-intensive sectors in Germany. Even investment in fixed assets showed a modest increase.

In 2012, investment in long-term fixed assets rose 2.4 percent to around EUR 930 million.

The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download